ELICERA THERAPEUTICS AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.065 SEK | +8.67% |
|
+12.34% | -76.64% |
| 28/03 | Elicera Therapeutics AB Announces Director Changes | CI |
| 06/03 | Elicera Enters Agreement with Prominent US Cancer Center to Evaluate the Use of ITANK in T-Cell Receptor Therapies | CI |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Equities
- ELIC Stock
- Revisions Elicera Therapeutics AB
